Williams Eugene
SEC Form 4 insider trading activity
Williams Eugene has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Nov 6, 2026.
On the most recent filing, Williams Eugene is listed as Director at ProMIS Neurosciences Inc. Inside the rolling window, Williams Eugene reported 6 open-market purchases totaling $237K in PMN and no open-market sales. The largest disclosed transaction in the window is a purchase of 26,500 PMN shares on Nov 4, 2026, worth $91K.
Companies traded
Other insiders at PMN
Insider Buying
$237K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Williams Eugene made?
Williams Eugene has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Williams Eugene trade?
Williams Eugene has filed SEC Form 4 disclosures for 1 company, including PMN.
When was Williams Eugene's most recent SEC Form 4 filing?
Williams Eugene's most recent SEC Form 4 filing on Tracefour is dated Nov 6, 2026.
What is Williams Eugene's total buy and sell value in the current window?
Inside the rolling retention window, Williams Eugene bought $237K and sold $0 based on SEC Form 4 filings.
What was Williams Eugene's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 26,500 PMN shares on 2026-11-04, worth $91K, per SEC Form 4 filings.